APA (7th ed.) Citation

A, M., S, M., SF, B., A, K., R, L., T, J., . . . RS, S. (2022). Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers. Pituitary, 25(2), 328. https://doi.org/10.1007/s11102-021-01201-z

Chicago Style (17th ed.) Citation

A, Madan, Markison S, Betz SF, Krasner A, Luo R, Jochelson T, Lickliter J, and Struthers RS. "Paltusotine, a Novel Oral Once-daily Nonpeptide SST2 Receptor Agonist, Suppresses GH and IGF-1 in Healthy Volunteers." Pituitary 25, no. 2 (2022): 328. https://doi.org/10.1007/s11102-021-01201-z.

MLA (9th ed.) Citation

A, Madan, et al. "Paltusotine, a Novel Oral Once-daily Nonpeptide SST2 Receptor Agonist, Suppresses GH and IGF-1 in Healthy Volunteers." Pituitary, vol. 25, no. 2, 2022, p. 328, https://doi.org/10.1007/s11102-021-01201-z.